Where does Revolution Medicines, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Revolution Medicines, Inc. ranks #8,904 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Revolution Medicines, Inc. hold?

Revolution Medicines, Inc. holds 36 US utility patents granted between 2019 and 2025, spanning 13 technology areas.

What is Revolution Medicines, Inc.'s Innovation Score?

Revolution Medicines, Inc. has an Innovation Score of 49.0 out of 100 (top 15% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Revolution Medicines, Inc. focus on?

Revolution Medicines, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 30 patents, ranking #655 of 6,058 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is Revolution Medicines, Inc.'s patent grant rate increasing or decreasing?

Revolution Medicines, Inc.'s recent grant velocity is +2500% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Revolution Medicines, Inc.'s patents?

Revolution Medicines, Inc.'s patents average 13.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Revolution Medicines, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Revolution Medicines, Inc.

USPTO PatentsView assignee record - 36 granted patents across 13 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Revolution ranks #8,904 of 49,997 tracked US assignees by granted-patent volume, with 36 patents across 13 technology areas.

#8,904
of 49,997 US assignees by volume: Top 15%
by Innovation Score (49.0/100): 13.3
avg claims per patent: +2500%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8904 · US Corporation #8,904 · 36 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 36 grants
UPPER-Q #8,904/49,997
PHOTO-FINISH Raynergy Tek…
CPC-FOCUS A61P · 13 areas
INNOV-PAR 49.0/100
CLAIMS-RICH 13.3 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +2500% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Raynergy Tek Incorporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Revolution’s 49.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.5 pts (26%) Velocity 15.8 pts (32%) Breadth 12.7 pts (26%) Claim depth 8.0 pts (16%)

Qualcomm Incorporated · highest

85
Fluid Energy Group · near

49
Movandi · near

49
Revolution Medicines · this assignee

49
Terra Quantum · near

49
Vitesco Germany · near

49
3D Lighting… · lowest

7

What this shows Revolution's Innovation Score is 49.0/100 (top 15% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Revolution?

Each dot is one of Revolution’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Revolution’s own 13.3 claims/patent is at or below the 15.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Revolution vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Revolution's grants concentrate

Revolution Medicines, Inc. is a focused PatentsView assignee: 13 CPC subclasses with 83.3% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2023 (13 grants) versus a trough of 1 in 2019. By volume, Revolution sits between Ruag Ammotec GmbH and Rockstar Consortium US LP.

Revolution's three-year grant acceleration

Revolution Medicines, Inc. shows 19 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ruag Ammotec

36
Rayvio

36
Raynergy Tek Inco…

36
Renmatix

36
Rio Tinto Alcan I…

36
Roadtec

36
Rockler Companies

36
Rockstar Consorti…

36
Revolution Medici… ◀

36

What this shows Revolution holds 36 patents at rank #8,905, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Revolution

By rank, the assignees closest to #8,905 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Revolution's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Revolution, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Revolution ranks #655 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (49 here).

Vitesco Technologies Germany GmbH 49 Movandi Corporation 49 Terra Quantum AG 49 Fluid Energy Group Ltd. 49

Revolution's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 15% higher than 85% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Revolution Medicines, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	2.8%
2020	2	5.6%
2021	5	13.9%
2022	2	5.6%
2023	13	36.1%
2024	4	11.1%
2025partial year	9	25.0%

Which technologies does Revolution Medicines, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 30

C07D - Heterocyclic Compounds 29

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 15

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

C07K - Peptides 3

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 3

C12Y - Enzymes 3

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 2

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 2

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 2

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Revolution Medicines, Inc.'s patent record in context - here's where to go next.

Revolution Medicines, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 83.3% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #8,904 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Revolution Medicines, Inc. against Ruag Ammotec GmbH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 49.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.